Physician profile
Mark D Wilson
NPI 1376535708
$1,242.81
in general payments reported to CMS, 2019-2025
10 companies · $62.77 in 2025
The $62.77 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $15.78 · 2021: $642 · 2022: $154 · 2023: $189 · 2024: $77.06 · 2025: $62.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $764.59 | 2021-2023 | Scopis Ent, Clarifix Cryotherapy Device |
| Genzyme Corporation | $128.44 | 2022-2024 | |
| Intersect Ent, INC. | $114.94 | 2019-2022 | |
| Acclarent, INC | $81.44 | 2019-2022 | |
| Boston Scientific Corporation | $47.04 | 2025 | Wavewriter Alpha Prime 16 |
| Aerin Medical INC. | $30.71 | 2022-2023 | |
| Optinose US, INC. | $25.95 | 2024 | |
| Shire North American Group INC | $17.38 | 2019 | |
| Olympus America INC. | $16.59 | 2022 | |
| Integra Lifesciences Corporation | $15.73 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.